The device is covered by Medicare but not by all commercial insurance, particularly Blue Cross Blue Shield.

Orforglipron's launch and Medicare/Medicaid eligibility will expand Eli Lilly's addressable market and offset price erosion.

Congressman Neal says access to health care is also important as an economic factor in the area. PITTSFIELD, Mass. — In a ...

Since 2000 prices at hospitals have soared by 250%—twice the overall rate for medical care and almost three times inflation. Hospitals now account for nearly a third of all American health-care ...

Greetings, and welcome to the HeartBeam Fourth Quarter 2025 Financial Results Conference Call. [Operator Instructions]. As a reminder, today's conference is being recorded. Before we begin the formal ...

Montana has been made to look like a center of political corruption. Rep. Ryan Zinke’s boss tweed move to insert his congressional candidate choice by perfectly timed exit, is an outrage. In what was ...

Detailed price information for Atea Pharmaceuticals Inc (AVIR-Q) from The Globe and Mail including charting and trades.

Earnings call Health Catalyst reported Q4 2025 revenue of $74.7M (down YoY), with full-year revenue up 1% to $311.1M and Adjusted EBITDA up 59% to $41.4M. Despite strong cost control and margin gains, ...

Why it matters and how it can transform your retirement.

What appeared to be a surge of grassroots support for higher Medicare Advantage payments was actually driven by a pro-industry group.

Don't assume it's the most cost-effective option.

Grail Inc’s latest earnings call struck a cautiously optimistic tone, balancing strong commercial and regulatory progress against meaningful clinical and financial uncertainties. Management ...